DK0972520T3 - Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 - Google Patents

Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52

Info

Publication number
DK0972520T3
DK0972520T3 DK98901044T DK98901044T DK0972520T3 DK 0972520 T3 DK0972520 T3 DK 0972520T3 DK 98901044 T DK98901044 T DK 98901044T DK 98901044 T DK98901044 T DK 98901044T DK 0972520 T3 DK0972520 T3 DK 0972520T3
Authority
DK
Denmark
Prior art keywords
freeze
bone morphogenetic
morphogenetic protein
human bone
dried composition
Prior art date
Application number
DK98901044T
Other languages
Danish (da)
English (en)
Inventor
Mitsuko Inagaki
Hideki Hoechst Marion Ichikawa
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of DK0972520T3 publication Critical patent/DK0972520T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98901044T 1997-01-30 1998-01-29 Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 DK0972520T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30
PCT/JP1998/000371 WO1998033514A1 (fr) 1997-01-30 1998-01-29 Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses

Publications (1)

Publication Number Publication Date
DK0972520T3 true DK0972520T3 (da) 2005-12-19

Family

ID=11913900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901044T DK0972520T3 (da) 1997-01-30 1998-01-29 Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52

Country Status (22)

Country Link
EP (1) EP0972520B9 (sr)
JP (1) JP4209948B2 (sr)
KR (1) KR100548107B1 (sr)
CN (1) CN1152712C (sr)
AP (1) AP983A (sr)
AT (1) ATE302021T1 (sr)
AU (1) AU737595B2 (sr)
BR (1) BR9807537B1 (sr)
CA (1) CA2278546C (sr)
DE (1) DE69831223T9 (sr)
DK (1) DK0972520T3 (sr)
EA (1) EA001579B1 (sr)
ES (1) ES2244043T3 (sr)
HU (1) HU226554B1 (sr)
IL (2) IL130967A0 (sr)
NO (1) NO322334B1 (sr)
NZ (1) NZ336509A (sr)
PL (1) PL189381B1 (sr)
RS (1) RS49691B (sr)
SI (1) SI0972520T1 (sr)
TR (1) TR199901832T2 (sr)
WO (1) WO1998033514A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4388602B2 (ja) † 1997-02-07 2009-12-24 ストライカー コーポレイション マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
WO2003030873A1 (en) * 2001-10-09 2003-04-17 Cellfactors Plc Therapeutic biological product and method for formation of new vascularised bone
CA2466947C (en) 2001-11-19 2012-05-22 Scil Technology Gmbh A homogeneously coated device having osteoinductive and osteoconductive properties
ATE322916T1 (de) 2002-09-10 2006-04-15 Scil Technology Gmbh Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat
EP1651272A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin as a stabiliser in vaccines
CA2545458A1 (en) * 2003-11-10 2005-05-26 Arriva-Prometic Inc. Dry recombinant human alpha 1-antitrypsin formulation
JP4944010B2 (ja) 2004-03-10 2012-05-30 サイル テクノロジー ゲーエムベーハー コーティングされたインプラント、その製造および使用
US10360287B2 (en) 2015-05-22 2019-07-23 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing user callouts
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU663328B2 (en) * 1991-06-21 1995-10-05 Genetics Institute, Llc Pharmaceutical formulations of osteogenic proteins
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
UA48105C2 (uk) * 1992-02-12 2002-08-15 Біофарм Гезельшафт Цур Біотехнологішен Ентвіклунг Вон Фармака Мбх ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
EP0814841B1 (en) * 1995-03-21 2001-12-05 Applied Research Systems ARS Holding N.V. Hcg liquid formulations
US7235527B2 (en) * 1995-04-19 2007-06-26 Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh Protein and process for producing the same

Also Published As

Publication number Publication date
IL130967A0 (en) 2001-01-28
SI0972520T1 (sl) 2006-02-28
DE69831223T9 (de) 2006-12-07
EA199900694A1 (ru) 2000-04-24
WO1998033514A1 (fr) 1998-08-06
HUP0002386A2 (hu) 2000-11-28
ES2244043T3 (es) 2005-12-01
CA2278546A1 (en) 1998-08-06
HUP0002386A3 (en) 2002-09-30
NO993702D0 (no) 1999-07-29
RS49691B (sr) 2007-12-31
DE69831223T2 (de) 2006-02-16
NO993702L (no) 1999-09-29
BR9807537A (pt) 2000-03-21
NZ336509A (en) 2001-03-30
KR20000070586A (ko) 2000-11-25
EP0972520B1 (en) 2005-08-17
ATE302021T1 (de) 2005-09-15
BR9807537B1 (pt) 2009-01-13
AU5679198A (en) 1998-08-25
AP9901602A0 (en) 1999-09-30
KR100548107B1 (ko) 2006-02-02
DE69831223D1 (de) 2005-09-22
TR199901832T2 (xx) 1999-12-21
NO322334B1 (no) 2006-09-18
CN1244127A (zh) 2000-02-09
AU737595B2 (en) 2001-08-23
IL130967A (en) 2006-12-10
YU34999A (sh) 2002-08-12
JP4209948B2 (ja) 2009-01-14
EA001579B1 (ru) 2001-06-25
CA2278546C (en) 2008-04-01
EP0972520A4 (en) 2002-11-05
PL334852A1 (en) 2000-03-27
HU226554B1 (en) 2009-03-30
EP0972520A1 (en) 2000-01-19
CN1152712C (zh) 2004-06-09
AP983A (en) 2001-07-16
PL189381B1 (pl) 2005-07-29
EP0972520B9 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
NO991271D0 (no) Benmorfogenetiske Protein-16-sammensetninger (BMP-16)
DE69624672D1 (de) Wirbelsäulenimplantat
DE69715264D1 (de) Knochenprothese
DE69722320D1 (de) Skelettimplantat
NO965208D0 (no) Benprotese
DE69630933D1 (de) Hohle Knochenprothese mit angepasster Flexibilität
FR2769495B1 (fr) Prothese de genou
DE69715348D1 (de) Hüftgelenkprothese
FR2722980B1 (fr) Implant vertebral inter-epineux
DE69711103D1 (de) Tibiale Prothese
BR9701466A (pt) Implante de área
DE69824876D1 (de) Knochenersatzmaterialien
BR9808777B1 (pt) Composição dentifrícia dessensibilizadora de dois componentes.
FR2734709B1 (fr) Prothese totale de genou
EP1095159A4 (en) Bone Morphogenetic Protein
DE19681408D2 (de) Additionsvernetzende 2-Komponenten-Siliconmaterialien
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE69826451D1 (de) Anästehischer knochenzement
ATA144897A (de) Wirbelsäulen-prothese
ATE250433T1 (de) Antibiotikumhaltige knochenzementpaste
DK0972520T3 (da) Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52
FR2767062B1 (fr) Composition comprenant de la propolis
FR2751528B1 (fr) Prothese de hanche
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
ID20994A (id) Komposisi penambal gigi